CyberKnife Market Size, Growth, Competitor and Outlook 2034

Global CyberKnife Market Size - By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Jun-2025 Report ID: MEDE2538 Pages: 1 - 232 Formats*:     
Category : Medical Devices
CyberKnife Market Introduction and Overview 

According to SPER Market Research, the Global CyberKnife Market is estimated to reach USD 3307.32 million by 2034 with a CAGR of 17.85%.

The report includes an in-depth analysis of the Global CyberKnife Market, including market size and trends, product mix, Applications, and supplier analysis. The Global CyberKnife Market was valued at USD 640 million in 2024 and is estimated to grow at a CAGR 17.85% from 2025 to 2034. The increasing demand for extremely precise and non-invasive cancer treatment options is driving a major expansion in the cyber knife market. CyberKnife is a robotic radiosurgery technology that is perfect for treating complicated and incurable cases because it can give targeted radiation therapy to malignancies with sub-millimeter accuracy. The market is expanding as a result of rising cancer rates, improvements in radiation technology, and rising demand for outpatient services. The widespread use of CyberKnife systems is also being aided by advantageous reimbursement regulations, growing healthcare investments, and ongoing product advancements.


By Application Insights
Cancer led the business and had a sizable market share in 2024. The American Cancer Society estimates that a large number of new cases will be diagnosed in the United States in 2023, with breast, prostate, lung, bronchial, and colorectal cancers being the five most prevalent cancer types. 
Because vascular malformations are so successful at treating arteriovenous malformations, they are anticipated to rise at the quickest rate during the projected period. This non-invasive, non-surgical technique closes the AVM by damaging the blood artery walls with a finely focused radiation beam.

By End User Insights
Driven by a growing number of patient visits and highly qualified personnel, the hospitals segment dominated the market and held a significant portion in 2024. The segment's growth is also fueled by hospitals expanding to accommodate patients' growing demands. During the forecast period, outpatient facilities are anticipated to increase at the quickest rate. Throughout the projected period, ambulatory surgery facilities and specialty clinics are expected to have significant growth. Benefits including shorter wait times and lower overall costs—including fewer out-of-pocket patient expenses—are the main causes of this growth.

Regional Insights
In 2024, the North American cyberknife market held a substantial revenue share, dominating the global market. The region's market is expanding due to a number of factors, including the growing incidence of chronic illnesses, a notable trend toward non-invasive and painless surgical procedures, and the growing need for effective therapies. Patient access to cutting-edge treatments is further improved by investments in healthcare infrastructure and advantageous reimbursement arrangements.



Market Competitive Landscape
Leading players in the global CyberKnife market are investing in R&D, technological innovation, and clinical trials to enhance treatment precision. Strategies include product launches, partnerships with healthcare providers, regulatory approvals, and geographic expansion to strengthen market presence and competitiveness. Some of the key market players are Accuray Incorporated, Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc., Ayasdi AI LLC, Baidu, Inc., Elekta AB, GE Healthcare, IBA Group.

Recent Developments:

  • In January 2025, Accuray Incorporated's Radixact SynC and CyberKnife S7 Systems were approved by China's National Medical Products Administration, increasing the company's radiation therapy options in the region. 
  • In June 2024, Heidelberg University Hospital in Germany made an investment in the Radixact System, which uses cutting-edge radiation therapy equipment from Accuray Incorporated to improve the care of cancer patients.
Scope of the report:
 Report Metric Details
 Market size available for years2021-2034
 Base year considered2024
 Forecast period2025-2034
 Segments coveredBy Application, By End User
 Regions coveredNorth America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
 Companies CoveredAccuray Incorporated, Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc, Ayasdi AI LLC, Baidu, Inc, Elekta AB, GE Healthcare, IBA Group.


Key Topics Covered in the Report
  • Global CyberKnife Market Size (FY’2021-FY’2034)
  • Overview of Global CyberKnife Market
  • Segmentation of Global CyberKnife Market By Application (Tumor, Cancer, Vascular Malformation, Others)
  • Segmentation of Global CyberKnife Market By End User (Hospitals, Outpatient Facilities, Research & Manufacturing)
  • Statistical Snap of Global CyberKnife Market
  • Expansion Analysis of Global CyberKnife Market
  • Problems and Obstacles in Global CyberKnife Market
  • Competitive Landscape in the Global CyberKnife Market
  • Details on Current Investment in Global CyberKnife Market
  • Competitive Analysis of Global CyberKnife Market
  • Prominent Players in the Global CyberKnife Market
  • SWOT Analysis of Global CyberKnife Market
  • Global CyberKnife Market Future Outlook and Projections (FY’2025-FY’2034)
  • Recommendations from Analyst
1. Introduction
  • 1.1. Scope of the report
  • 1.2. Market segment analysis
2. Research Methodology
  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation
3. Executive Summary

4. Market Dynamics
  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
5. Market variable and outlook
  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces 
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis
6. Competitive Landscape
  • 6.1. Global CyberKnife Market Manufacturing Base Distribution, Sales Area, Product Type 
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global CyberKnife Market
7. Global CyberKnife Market, By Application (USD Million) 2021-2034
  • 7.1. Tumor
  • 7.2. Cancer
  • 7.3. Vascular Malformation
  • 7.4. Others
8. Global CyberKnife Market, By End User (USD Million) 2021-2034
  • 8.1. Hospitals
  • 8.2. Outpatient Facilities
  • 8.3. Research & Manufacturing
9. Global CyberKnife Market, (USD Million) 2021-2034
  • 9.1. Global CyberKnife Market Size and Market Share
10. Global CyberKnife Market, By Region, (USD Million) 2021-2034
  • 10.1. Asia-Pacific
    • 10.1.1. Australia
    • 10.1.2. China
    • 10.1.3. India
    • 10.1.4. Japan
    • 10.1.5. South Korea
    • 10.1.6. Rest of Asia-Pacific
  • 10.2. Europe
    • 10.2.1. France
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Spain
    • 10.2.5. United Kingdom
    • 10.2.6. Rest of Europe
  • 10.3. Middle East and Africa
    • 10.3.1. Kingdom of Saudi Arabia 
    • 10.3.2. United Arab Emirates
    • 10.3.3. Qatar
    • 10.3.4. South Africa
    • 10.3.5. Egypt
    • 10.3.6. Morocco
    • 10.3.7. Nigeria
    • 10.3.8. Rest of Middle-East and Africa
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. Mexico
    • 10.4.3. United States
  • 10.5 .Latin America
    • 10.5.1. Argentina
    • 10.5.2. Brazil
    • 10.5.3. Rest of Latin America 
11. Company Profile
  • 11.1. Accuray Incorporated
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary 
    • 11.1.4. Recent developments
  • 11.2. Advanced Micro Devices
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary 
    • 11.2.4. Recent developments
  • 11.3. AiCure
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary 
    • 11.3.4. Recent developments
  • 11.4. Arm Limited
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary 
    • 11.4.4. Recent developments
  • 11.5. Atomwise, Inc
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary 
    • 11.5.4. Recent developments
  • 11.6. Ayasdi AI LLC
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary 
    • 11.6.4. Recent developments
  • 11.7. Baidu, Inc
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary 
    • 11.7.4. Recent developments
  • 11.8. Elekta AB
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary 
    • 11.8.4. Recent developments
  • 11.9. GE Healthcare
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary 
    • 11.9.4. Recent developments
  • 11.10. IBA Group
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary 
    • 11.10.4. Recent developments
  • 11.11. Others
12. Conclusion

13. List of Abbreviations

14. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3


Frequently Asked Questions About This Report
CyberKnife Market is covered By Application, By End User
CyberKnife Market is projected to reach USD 3307.32 million by 2034, growing at a CAGR of 17.85% during the forecast period.
CyberKnife Market grew in Market size from 2025. The Market is expected to reach USD 3307.32 million by 2034, at a CAGR of 17.85% during the forecast period.
CyberKnife Market CAGR of 17.85% during the forecast period.
You can get the sample pages by clicking the link - Click Here
CyberKnife Market size is USD 3307.32 million from 2025 to 2034.
The North America is anticipated to have the highest Market share in the CyberKnife Market.
Accuray Incorporated, Advanced Micro Devices, AiCure, Arm Limited, Atomwise, Inc, Ayasdi AI LLC, Baidu, Inc, Elekta AB, GE Healthcare, IBA Group.
The report includes an in-depth analysis of the Global CyberKnife Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
  • 15 % off
     
    $ 4250
  • 20 % off
             
    $ 5650
  • 25 % off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
CALL OR EMAIL US
US:
India:
Email:
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Have a glance of the Report

  Download Free Sample

Looking for Customization?

 Customization Request

Have a Question?

 Reach Our Analysis Team

COVID-19 impact analysis?

 Request Analysis

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken